MDWD
MediWound Ltd.
MDWD's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MDWD overall, supported by stronger fundamentals and stronger modeled upside.
MDWD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Strong |
MDWD's balance sheet is currently strong, but its revenue, profitability and cash flow are weak.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MDWD PE Valuation
MDWD has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MDWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect MDWD's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MDWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.60 | +$1.04 |
| Q1 2026 | -$2.26 | -$0.17 |
| Q4 2025 | -$2.10 | +$0.97 |
| Q3 2025 | -$1.90 | +$1.00 |
| Q2 2025 | -$2.64 | -$0.48 |
| Q1 2025 | -$2.09 | -$0.71 |
| Q4 2024 | -$3.07 | -$2.30 |
| Q3 2024 | -$2.90 | -$1.14 |
MDWD is still losing money, but far less than before: $1.60 per share over the past year, against $3.85 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MDWD on earnings quality, reporting a profit while its opponent remains loss making.
MDWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.1M | -46% |
| Q1 2026 | $1.5M | -63% |
| Q4 2025 | $1.9M | -68% |
| Q3 2025 | $5.4M | +25% |
| Q2 2025 | $5.7M | +13% |
| Q1 2025 | $4M | -20% |
| Q4 2024 | $5.8M | +9.4% |
| Q3 2024 | $4.4M | -8.8% |
MDWD's revenue has slid since its 2022 peak: $3M last quarter, down 46% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -306% | -206 points |
| Q1 2026 | -541% | -409 points |
| Q4 2025 | -418% | -314 points |
| Q3 2025 | -120% | -3.5 points |
| Q2 2025 | -100% | -12 points |
| Q1 2025 | -132% | -57 points |
| Q4 2024 | -104% | -31 points |
| Q3 2024 | -117% | -53 points |
MDWD's operating margin was −306% last quarter, down 206 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over MDWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MDWD on profitability, with a higher operating margin.
MDWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$10.1M | -$3.3M |
| Q1 2026 | -$8.6M | -$3.5M |
| Q4 2025 | -$5.5M | -$3M |
| Q3 2025 | -$4.3M | +$664K |
| Q2 2025 | -$6.8M | -$166K |
| Q1 2025 | -$5.1M | +$193K |
| Q4 2024 | -$2.4M | +$2.4M |
| Q3 2024 | -$4.9M | -$12K |
MDWD has burned cash in almost every quarter: −$28M over the past year, against −$19M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MDWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
MDWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +9.8K shares |
| 1 year | +19% | +2M shares |
| 3 years | +40% | +3.7M shares |
| 5 years | +231% | +9M shares |
| Available history | +232% | +9M shares |
MDWD has 13M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $747,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
MDWD spent $747,000 buying back its own shares over the past year, after none the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over MDWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MDWD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | -11.2x | Net Cash |
| Q4 2023 | -2.1x | Net Cash |
| Q1 2020 | -1.1x | Net Cash |
| Q4 2019 | -1.3x | Net Cash |
| Q3 2019 | -0.5x | Net Cash |
MDWD has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MDWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 59.4 | Neutral |
MDWD's weekly RSI is 44 (neutral) and its Stochastic is 59 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MDWD PE vs Healthcare Sector
| Metric | MDWD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MDWD has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MDWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 0.5% below |
| 20 week MA | $13.5 | 4.1% below |
| 50 week MA | $15.5 | 17% below |
| 100 week MA | $16.9 | 23% below |
| 200 week MA | $15.1 | 14% below |
MDWD is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MDWD on trend strength, trading above more of its moving averages.
MDWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.1 | $28.6 | +35% |
| 2021 | $28.6 | $15.8 | -45% |
| 2022 | $15.8 | $11.5 | -27% |
| 2023 | $11.5 | $10.2 | -12% |
| 2024 | $10.2 | $17.7 | +74% |
| 2025 | $17.7 | $18.8 | +6.2% |
| 2026 YTD | $18.8 | $13.0 | -31% |
MDWD has finished lower in three of the last six years. It's down 31% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MDWD on returns for 2026, with the stronger performance.